drugset / Trial / NCT04610125
Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children
Unknown
30 enrolled
Hebei Senlang Biotechnology Inc., Ltd.
Hebei Medical University Fourth Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
This is an open, single-arm, prospective，clinical study to evaluate efficacy and safety of Auto CAR-T cell injection in the treatment of recurrent or refractory Hematopoietic and Lymphoid Tissue Tumors in Children
Timeline
- Start
- 2020-06-23
- Primary completion
- 2023-06-22
- Completion
- 2025-06-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Auto CAR-T | Cell therapy | — | — |
| Background | Cyclophosphamide | Other / unclassified | — | — |
| Background | Fludarabine | Small molecule | — | — |